Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?Case report Published on 2020-07-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] SARS, 치료법, [키워드] China Clinical prognosis complications coronavirus 2 COVID-19 COVID-19 affected patients D-dimer death discharged disease effective Elderly patient elevated high risk higher risk Hospitalization lymphopenia Mild Multiple multiple sclerosis no symptoms pandemic Patient patients with comorbidity potential therapy Potential treatment respiratory Result sclerosis Support Symptom tested the patient therapy thought treated Treatment type 1 interferon [DOI] 10.1016/j.msard.2020.102196 [Article Type] Case report
Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patientsConcise Communication Published on 2020-06-082022-10-30 Journal: Infection Control and Hospital Epidemiology [Category] COVID-19, SARS, [키워드] COVID-19 pandemic COVID-19 patient COVID-19 patients management potential therapy repurposing the patient [DOI] 10.1017/ice.2020.281 PMC 바로가기 [Article Type] Concise Communication
Nicotinamide Riboside—The Current State of Research and Therapeutic UsesReview Published on 2020-05-312022-10-30 Journal: Nutrients [Category] COVID-19, MERS, SARS, [키워드] addition addressed age-associated diseases available data benefit Bioavailability Cardiovascular disorders condition COVID-19 current Effect Efficiency elevated Evidence Health increases in Infection Metabolic disorders metabolic pathway metabolism morbidity neurodegenerative nicotinamide adenine dinucleotide nicotinamide riboside Pathogens pathophysiological conditions potential therapy precursors Prevalence Research riboside Safety SARS-CoV-2 state Supplementation Support therapeutic use translation Treatment variety [DOI] 10.3390/nu12061616 PMC 바로가기 [Article Type] Review
Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infectionSpecial Article Published on 2020-05-292022-10-31 Journal: Einstein [Category] COVID-19, MERS, SARS, [키워드] acute renal failure acute respiratory distress acute respiratory syndrome Betacoronavirus China Confirmed COVID-19 infection Controlled clinical trial Coronavírus coronavirus COVID-19 DESSA develop diagnosed form hypoxemic infecção Insuficiência respiratória intensive care intensive care units Patient Pneumonia potential therapy progressed randomizado Randomized recommendation recommendations renal Respiratory distress syndrome, adult Respiratory failure respiratory insufficiency Síndrome do desconforto respiratório do adulto SARS-CoV-2 severe pneumonia Support syndrome the disease Treatment Unidades de terapia intensiva Wuhan [DOI] 10.31744/einstein_journal/2020AE5793 PMC 바로가기 [Article Type] Special Article
Mesenchymal stem cells as a potential therapy for COVID-19Commentary Published on 2020-05-042022-10-29 Journal: Stem Cell Research & Therapy [Category] COVID-19, MERS, [키워드] 2019 novel coronavirus ALI ARDS cause cellular characterized clinical trial COVID-19 Critical disease distress effective hyaline membrane formation Inflammatory response lung mesenchymal stem cell MSC MSCs outbreak pathologic feature potential therapy presenting Pulmonary edema pulmonary inflammation raise Severe case specific treatment syndrome therapy Treatment [DOI] 10.1186/s13287-020-01678-8 PMC 바로가기 [Article Type] Commentary
Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature ReviewReview Article Published on 2020-01-012022-10-30 Journal: Iranian Journal of Pharmaceutical Research : IJPR [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) approach ARDS caused China clinical manifestations clinical trial coronavirus coronavirus 2 Coronavirus disease 2019 COVID-19 COVID-19 disease disease drugs targeting effective effective drug effort elements host cell identify knowledge literature medication Mild moderate new virus offered outcomes pandemic Pharmacologic potential therapy public health Quickly respiratory review SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus severity Spread Stage suggested syndrome the disease therapy Treatment View virus [DOI] 10.22037/ijpr.2020.113821.14506 PMC 바로가기 [Article Type] Review Article
A review of candidate therapies for Middle East respiratory syndrome from a molecular perspectiveReview Published on 2017-09-302022-10-29 Journal: Journal of Medical Microbiology [Category] Coronavirus, MERS, [키워드] acute respiratory syndrome Antibiotics antiviral peptide camostat cathepsin L clinical trials Combination Controlled clinical trial convalescent convalescent plasma Corticosteroids current therapy DPP4 East effective furin protease GLS-5300 glycopeptide antibiotic high mortality rate host proteases include inhibitor interferon interferons laboratory-confirmed Lopinavir Lopinavir–ritonavir M(pro) Medline database MERS-CoV Middle East molecular monoclonal antibodies mortality rate Mutation pandemic Perspective PL(pro) potential therapy protease required respiratory syndrome coronavirus ribavirin S protein SARS-CoV searched subject syndrome Therapies therapy TMPRSS2 Transmissibility urgency Vaccine vaccine candidates Variation viral S protein [DOI] 10.1099/jmm.0.000565 PMC 바로가기 [Article Type] Review